Items Tagged ‘ductal carcinoma in situ’

June 9th, 2015

Arimidex® More Effective than Tamoxifen in Prevention of Recurrence in Early Breast Cancer


For patients with a common type of breast cancer known as ductal carcinoma in situ (DCIS), the drug Arimidex® (anastrozole) may provide better protection against recurrence than tamoxifen. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical […]

View full entry

Tags: anastrozole, Arimidex, Breast Cancer, Carcinoma In Situ Breast cancer, DCIS, ductal carcinoma in situ, News, tamoxifen